← Back to Search

10 mg THC for Endurance Exercise

N/A
Waitlist Available
Research Sponsored by Christopher Bell
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Habitual exerciser: exercised a minimum of 5 days per week, for a minimum of 30-minutes/session, during the previous year.
Weigh more than 110 pounds
Timeline
Screening 3 weeks
Treatment Varies
Follow Up separated by a minimum of a 4 day washout period between randomized crossover coded interventions
Awards & highlights

Study Summary

This trial will study the effects of marijuana on exercise performance in regular users.

Eligible Conditions
  • Endurance Exercise

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are over 110 pounds.
Select...
You are between the ages of 21 and 40.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~separated by a minimum of a 4 day washout period between randomized crossover coded interventions
This trial's timeline: 3 weeks for screening, Varies for treatment, and separated by a minimum of a 4 day washout period between randomized crossover coded interventions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison of Blood Lactate Levels during a 24 minute graded standard exercise test (50 watts, 100 watts, and 150 watts) to placebo.
Comparison of Heart Rate during a 24 minute graded standard exercise test (50 watts, 100 watts, and 150 watts) to placebo.
Comparison of Indirect Calorimetry (VO2) during a 24 minute graded standard exercise test (50 watts, 100 watts, and 150 watts) to placebo.
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 10 mg THCActive Control1 Intervention
Delta-9-tetrahydrocannabinol (THC) 5 milligrams (mg) in gummy form. One time, two gummies will be ingested prior to an exercise bout.
Group II: PlaceboPlacebo Group1 Intervention
Delta-9-tetrahydrocannabinol (THC) free fruit snack gummy. One time, two gummies will be ingested prior to an exercise bout.

Find a Location

Who is running the clinical trial?

Christopher BellLead Sponsor
7 Previous Clinical Trials
187 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently availabilities for participants to join this experimentation?

"Clinicaltrials.gov reveals that this research effort, which was initially published on December 9th 2021 and recently amended on August 29th 2022, is no longer recruiting individuals. Nonetheless, 117 other trials are presently seeking participants."

Answered by AI

Is this investigation seeking volunteers who are older than 40 years?

"In order to meet the requirements for study participation, prospective patients must be between 21 and 40 years old."

Answered by AI

Who would be a suitable candidate for participation in this research initiative?

"Eligibility for this trial requires that participants are within the ages of 21 and 40, have a history with cannabis use disorder, and are one of the 11 lucky people."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
How old are they?
18 - 65
What site did they apply to?
Colorado State University, Dept. of Health and Exercise Science
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Influence of Edible Marijuana on Endurance Exercise Performance
Christopher Bell 2021. "Influence of Edible Marijuana on Endurance Exercise Performance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05192239.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top